Market capitalization | $8.47b |
Enterprise Value | $9.02b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 53.89 |
EV/Sales (TTM) EV/Sales | 4.57 |
P/S ratio (TTM) P/S ratio | 4.29 |
P/B ratio (TTM) P/B ratio | 8.94 |
Revenue growth (TTM) Revenue growth | -0.12% |
Revenue (TTM) Revenue | $1.97b |
As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.
10 Analysts have issued a Masimo Corporation forecast:
10 Analysts have issued a Masimo Corporation forecast:
Mar '25 |
+/-
%
|
||
Revenue | 1,974 1,974 |
0%
0%
|
|
Gross Profit | 997 997 |
4%
4%
|
|
EBITDA | 172 172 |
34%
34%
|
EBIT (Operating Income) EBIT | 85 85 |
49%
49%
|
Net Profit | -495 -495 |
724%
724%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.
Head office | United States |
CEO | Catherine Szyman |
Employees | 9,200 |
Founded | 1989 |
Website | www.masimo.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.